Nutra Pharma Corp.
NPHC
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 09/30/2022 | 09/30/2022 | 06/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 52.89% | 189.38% | 189.38% | -112.88% | -112.88% |
| Total Depreciation and Amortization | 1.65% | -2.28% | -2.28% | -9.13% | -9.13% |
| Total Amortization of Deferred Charges | -52.29% | 2.32% | 2.32% | 0.22% | 0.22% |
| Total Other Non-Cash Items | -76.53% | -854.27% | -848.26% | 102.49% | 102.51% |
| Change in Net Operating Assets | -99.69% | 95.45% | 98.95% | -9.92% | -10.08% |
| Cash from Operations | -101.29% | 41.96% | 41.96% | -10.30% | -10.30% |
| Capital Expenditure | -- | -- | -- | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -198.00% | 560.00% | 560.00% | -162.50% | -162.50% |
| Cash from Investing | -198.00% | 560.00% | 560.00% | 83.06% | 83.06% |
| Total Debt Issued | 36.27% | -37.44% | -27.29% | 15.24% | 117.76% |
| Total Debt Repaid | 33.39% | -34.47% | -34.47% | 6.84% | 6.84% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -- | -70.46% |
| Cash from Financing | 137.56% | -64.32% | -64.32% | 26.45% | 26.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -397.14% | -397.14% | 104.17% | 104.17% |